Equities analysts forecast that The Advisory Board Company (NASDAQ:ABCO) will announce sales of $202.29 million for the current quarter, according to Zacks Investment Research. Ten analysts have made estimates for The Advisory Board’s earnings, with estimates ranging from $194.00 million to $210.70 million. The Advisory Board posted sales of $200.46 million in the same quarter last year, which would indicate a positive year over year growth rate of 0.9%. The company is expected to report its next earnings results on Tuesday, November 7th.
On average, analysts expect that The Advisory Board will report full year sales of $202.29 million for the current financial year, with estimates ranging from $792.87 million to $819.50 million. For the next year, analysts expect that the firm will post sales of $845.76 million per share, with estimates ranging from $821.50 million to $862.00 million. Zacks’ sales averages are a mean average based on a survey of sell-side analysts that follow The Advisory Board.
The Advisory Board (NASDAQ:ABCO) last released its earnings results on Tuesday, August 8th. The business services provider reported $0.24 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.32 by ($0.08). The Advisory Board had a return on equity of 12.69% and a net margin of 13.65%. The company had revenue of $200.30 million during the quarter, compared to analyst estimates of $196.16 million. During the same period in the prior year, the business posted $0.46 earnings per share. The Advisory Board’s revenue was up 1.0% on a year-over-year basis.
ABCO has been the topic of several research analyst reports. Zacks Investment Research cut The Advisory Board from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, July 25th. Wells Fargo & Company cut The Advisory Board from an “outperform” rating to a “market perform” rating and lowered their price target for the company from $57.00 to $54.00 in a research note on Monday, October 2nd. Cantor Fitzgerald reissued a “hold” rating and issued a $54.00 price target (up previously from $45.00) on shares of The Advisory Board in a research note on Tuesday, August 29th. Stifel Nicolaus reissued a “hold” rating and issued a $53.00 price target (up previously from $48.00) on shares of The Advisory Board in a research note on Thursday, July 6th. Finally, Oppenheimer Holdings, Inc. reissued an “outperform” rating and issued a $56.00 price target (up previously from $53.00) on shares of The Advisory Board in a research note on Thursday, August 10th. Two analysts have rated the stock with a sell rating, twelve have assigned a hold rating and three have issued a buy rating to the stock. The company currently has a consensus rating of “Hold” and an average target price of $51.95.
COPYRIGHT VIOLATION NOTICE: This piece of content was published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this piece of content on another site, it was illegally copied and republished in violation of U.S. & international copyright and trademark laws. The legal version of this piece of content can be accessed at https://www.dispatchtribunal.com/2017/11/12/202-29-million-in-sales-expected-for-the-advisory-board-company-abco-this-quarter-2.html.
Institutional investors have recently made changes to their positions in the business. Victory Capital Management Inc. bought a new stake in The Advisory Board during the first quarter worth approximately $109,000. Rockefeller Financial Services Inc. bought a new stake in The Advisory Board during the second quarter worth approximately $137,000. Eqis Capital Management Inc. bought a new stake in The Advisory Board during the second quarter worth approximately $204,000. First Capital Advisors Group LLC. bought a new stake in The Advisory Board during the second quarter worth approximately $221,000. Finally, Cubist Systematic Strategies LLC bought a new stake in The Advisory Board during the second quarter worth approximately $221,000.
The Advisory Board (NASDAQ:ABCO) remained flat at $53.90 during midday trading on Tuesday. The company had a trading volume of 553,924 shares. The firm has a market capitalization of $2.19 billion, a P/E ratio of 20.47 and a beta of 1.33. The Advisory Board has a 52 week low of $24.85 and a 52 week high of $59.50. The stock has a 50-day moving average price of $53.66 and a 200 day moving average price of $52.43.
The Advisory Board Company Profile
The Advisory Board Company is a provider of software and solutions to the healthcare and higher education industries. The Company offers subscription-based membership programs, software and data-enabled services. All of its programs are rooted in best practices and extends across four areas, including Best practices research, Technology, Data-enabled services and Consulting services.
Get a free copy of the Zacks research report on The Advisory Board (ABCO)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for The Advisory Board Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Advisory Board Company and related companies with MarketBeat.com's FREE daily email newsletter.